|
|
AGENDA |
|
| MORNING SESSION |
|
| |
08:00-09:20AM |
Registration / Networking / Breakfast |
|
| |
09:20-09:25AM |
Welcoming Remarks |
| |
|
Yanhong Lin, Managing Partner, CTIC Capital |
| |
09:25-10:10AM |
Keynote Speech: Prospects for Use of Exosomes in Cancer Diagnosis and Treatment |
| |
|
Randy W. Schekman, Nobel laureate, the 2013 Nobel Prize in Physiology or Medicine |
| |
10:10-10:55AM |
Panel Discussion I: Chinese Investment & M&A Opportunities – Where Is the Money? |
| |
|
Alexis Ji, Parnter, Illumina Ventures (Panel Lead)
James Huang, Managing Partner, KPCB China
Hongbo Lu, Partner, Lilly Asia Ventures
Xiaobo Lu, Partner, Sequoia Capital China
Jerry Xiao, CEO, Hermed Capital |
| |
10:55-11:40AM |
Panel Discussion II: Successful Equity Investments and M&A & Why Others Failed |
| |
|
Karen Wong, Partner, Intellectual Property, WSGR (Panel Lead)
Hai Mi, Founding Managing Partner, Panacea Venture
Christopher Shen, Managing Partner, Qiming Venture Parners
Alvin Syh, CEO, Buchang Asset Management; General Manager, Anrich Capital Asia
Grace Xu, SVP for Biomedicine Business, SanPower; Chairwoman, Denderon Corporation |
| |
11:40-12:55PM |
Lunch / Special Session Hosted by WSGR: Capitalizing On Cross-Border Healthcare Investments, M&A, and Public Offerings |
| |
|
Michael Chan, SVP, Hong Kong Exchanges and Clearing Ltd.("HKEX")
Derek Liu, Partner-Elect, Mergers & Acquisitions, WSGR
Khoon Jin Tan, Partner, Corporate, WSGR
Barry Taylor, Partner, Corporate, WSGR
Karen Wong, Partner, Intellectual Property, WSGR |
|
| AFTERNOON SESSION |
|
| |
12:55-01:55PM |
Company Presentations: Epic Sciences, Tessa Therapeutics, Sera Prognostics |
| |
|
Hongjie Hu, Investment Director, Temasek
Yingying Chen, Executive Director, GF Investments (Hong Kong) Company Limited
Jiang Zhang, Managing Director, Ping An Venture |
| |
01:55-02:40PM |
Panel Discussion III: US Healthcare Investment Trend – Where Would the US VCs Invest in Healthcare? |
| |
|
Doug Fisher, Partner, InterWest Partners (Panel Lead)
Ted Driscoll, Managing Director, DigitalDx Ventures
Julie Papanek Grant, Partner, Canaan
Patrick Heron, Managing General Partner, Frazier Healthcare Partners
Amy Schulman, Entrepreneur Partner, Polaris Partners |
| |
02:40-02:55PM |
Break |
|
| |
02:55-03:55PM |
Company Presentations: Quantapore, BioClin Therapeutics, Connect Biopharma |
| |
|
Kevin Chen, Founding Partner, Biotrack Capital
Lily Zhang, Partner, CDH Venture
David Flores, Co-Founder, President & CEO, BioCentury |
| |
03:55-04:40PM |
Panel Discussion IV: Cross-Border Business Development, Joint Venture, and Licensing Opportunities |
| |
|
Samantha Du, Chairman and CEO, Zai Lab
Nisa Leung, Managing Partner, Qiming Ventures Partners
Frank Zhang, CEO, GenScript; Chairman, Nanjing Legend
Richard Zhao, GM Strategy and Investment & SVP, Medical Device, Fosun Pharma |
|
| |
04:40-05:00PM |
Closing |
|
| |
05:00-07:00PM |
Networking |
| |
|
|
|
|
|
